Morley Stephanie 4
4 · Zomedica Pharmaceuticals Corp. · Filed Apr 24, 2018
Insider Transaction Report
Form 4
Morley Stephanie
COO & VP of Product Dev
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2018-04-20−104,000→ 0 totalExercise: $0.20From: 2016-03-28Exp: 2018-04-21→ Common Shares, without par value (104,000 underlying) - Exercise/Conversion
Common Shares, without par value
2018-04-20$0.20/sh+104,000$20,800→ 1,459,580 total
Holdings
- 1,000(indirect: By step-son)
Common Shares, without par value
- 1,000(indirect: By daughter)
Common Shares, without par value
- 1,000(indirect: By daughter)
Common Shares, without par value
- 1,000(indirect: By step-son)
Common Shares, without par value
- 1,000(indirect: By step-daughter)
Common Shares, without par value